Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Morani

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 16, 2015
Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturerMaurizio Landolina, Antonio Curnis, Giovanni Morani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2013
Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian RegistryGiovanni Morani, Maurizio Gasparini, Francesco Zanon, et al.
Heart (British Cardiac Society)|April 1, 2014
Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillatorsRenato Pietro Ricci, Carlo Pignalberi, Maurizio Landolina, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 3, 2018
Patients with right bundle branch block and concomitant delayed left ventricular activation respond to cardiac resynchronization therapyGianni Pastore, Giovanni Morani, Massimiliano Maines, et al.
Journal of Cardiovascular Electrophysiology|April 29, 2025
Outcomes of Micra Leadless Pacemaker Implants in Centers With and Without Cardiac SurgeryGianluca Manzo, Gabriele Giannola, Gerardo Nigro, et al.
International Journal of Cardiology|January 3, 2017
Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigationMauro Biffi, Matteo Ziacchi, Renato Pietro Ricci, et al.
American Journal of Cardiovascular Disease|January 31, 2019
Prediction of mortality in patients with implantable defibrillator using CHADS2 score: data from a prospective observational investigationGiovanni Morani, Domenico Facchin, Giulio Molon, et al.
International Journal of Cardiology|February 14, 2025
Leadless Micra pacemakers: Estimating long-term longevity. A real word data analysisDomenico Maria Carretta, Luca Tomasi, Claudio Tondo, et al.
Diabetes Care|May 26, 2016
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter MonitoringAlessandro Mantovani, Antonio Rigamonti, Stefano Bonapace, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 15, 2021
Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?Maurizio Landolina, Giuseppe Boriani, Mauro Biffi, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 16, 2015
Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturerMaurizio Landolina, Antonio Curnis, Giovanni Morani, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2013
Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian RegistryGiovanni Morani, Maurizio Gasparini, Francesco Zanon, et al.
Heart (British Cardiac Society)|April 1, 2014
Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillatorsRenato Pietro Ricci, Carlo Pignalberi, Maurizio Landolina, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 3, 2018
Patients with right bundle branch block and concomitant delayed left ventricular activation respond to cardiac resynchronization therapyGianni Pastore, Giovanni Morani, Massimiliano Maines, et al.
Journal of Cardiovascular Electrophysiology|April 29, 2025
Outcomes of Micra Leadless Pacemaker Implants in Centers With and Without Cardiac SurgeryGianluca Manzo, Gabriele Giannola, Gerardo Nigro, et al.
International Journal of Cardiology|January 3, 2017
Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigationMauro Biffi, Matteo Ziacchi, Renato Pietro Ricci, et al.
American Journal of Cardiovascular Disease|January 31, 2019
Prediction of mortality in patients with implantable defibrillator using CHADS2 score: data from a prospective observational investigationGiovanni Morani, Domenico Facchin, Giulio Molon, et al.
International Journal of Cardiology|February 14, 2025
Leadless Micra pacemakers: Estimating long-term longevity. A real word data analysisDomenico Maria Carretta, Luca Tomasi, Claudio Tondo, et al.
Diabetes Care|May 26, 2016
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter MonitoringAlessandro Mantovani, Antonio Rigamonti, Stefano Bonapace, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 15, 2021
Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?Maurizio Landolina, Giuseppe Boriani, Mauro Biffi, et al.
Pageof 5